Table 2 Effect of PMCA4 inhibition of ATA on the body weight changes and the red blood cells concentrations
Dosage | Day post infection | Monitoring indicators | ||||
|---|---|---|---|---|---|---|
Body weight | RBC | |||||
Weight (g) | Loss (%) | Count | Concentrations | Loss (%) | ||
Sulfadoxine 25 mg/kg BW | 1 | 20.75 (± .50) | 0 | 89 (± 12.25) | 4.5E+09 (± 6.1E+08) | 0 |
9 | 21.25 (± 1.71) | 2.41 | 78 (± 14.31) | 3.9E+09 (± 7.2E+08) | − 12.36 | |
14 | 21.75 (± 1.26) | 4.82 | 101.5 (± 19.28) | 5.1E+09 (± 9.6E+08) | 14.04 | |
Untreated | 1 | 20.2 (± 1.48) | 0 | 73.4 (± 10.31) | 3.7E + 09 (± 5.2E+08) | 0 |
9 | 21.2 (± .84) | 4.95 | 45 (± 12.23) | 2.3E+09 (± 6.1E+08) | − 38.69 | |
14 | 18.4 (± .55) | − 8.91 | 32 (± 9.08) | 1.6E+09 (± 4.5E+08) | − 56.40 | |
ATA 30 mg/kg BW | 1 | 17.00 (± 1.83) | 0 | 69.7 (± 11.67) | 3.5E+09 (± 5.8E+08) | 0 |
9 | 16.57 (± .53) | − 2.52 | 61 (± 13.60) | 3.1E+09 (± 6.8E+08) | − 12.50 | |
14 | 16.17 (± .98) | − 4.90 | 36.3 (± 17.04) | 1.8E+09 (± 8.5E+08) | − 47.95 | |